Clinical trials
Active, not recruiting Phase 1/2 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| BicycleTx Limited | 2 |
| Kari Wisinski | 2 |
| National Cancer Institute (NCI) | 2 |
| Antonio Giordano, MD | 1 |
| Bristol-Myers Squibb | 1 |
| Cancer Research UK | 1 |
| Gilead Sciences | 1 |
| Immunitas Therapeutics | 1 |
| Jules Bordet Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 19 |
| Breast Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Neoplasm Metastasis | 4 |
| Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Urinary Bladder Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
| Colorectal Neoplasms | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.